Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Statement re. Suspension

3 Apr 2006 16:32

Capricorn Resources PLC03 April 2006 CAPRICORN RESOURCES PLC SUSPENSION OF TRADING The Directors of Capricorn Resources PLC ("Capricorn") note that trading in itsOrdinary Shares and Warrants on the AIM Market of the London Stock Exchange hasbeen suspended today under the rule relating to investing companies. TheDirectors further note that, unless Capricorn completes a reverse transaction inaccordance with the rules, its admission to AIM will be cancelled on 30September 2006. The Directors of Capricorn have reached agreement in principle for theacquisition of a company operating in the on-shore natural gas sector in theUnited Kingdom, and holding a petroleum licence which includes a small gas fieldin Derbyshire. The recent increase in gas prices mean that it can be economic toproduce gas from a small field and the intention is to bring this field intoproduction within six months of completion of the acquisition. The licence alsoincludes abandoned mine workings and it will be Capricorn's intention in thelonger term to explore for and produce coal bed methane, including gasassociated with abandoned mine workings, both on this licence and in other areasof Great Britain, and to develop gas storage facilities within such workings. The proposed acquisition will be conditional, inter alia, on completion of duediligence, including a valuation of the assets to be acquired, on the raising offurther cash intended to be provided by the exercise of part of Capricorn'soutsanding Warrants, and on confirmation of certain regulatory matters. Amongthe requirements is approval by Capricorn shareholders in general meeting as aspecial resolution. As one shareholder grouping controls more than 25% ofCapricorn's shares the approval of that group is essential for any resolution tobe passed and will be sought by the Directors prior to signing a bindingcontract. Should this agreement not be forthcoming the transaction will not be able toproceed, and for that reason the Directors will continue to examine otherpossible deals with a view to completing a transaction before 30 September 2006. Shareholders will be kept informed of developments. Contact: Brian Moritz (Chairman) 07976 994300 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jul 20195:02 pmRNSHolding(s) in Company
5th Jul 201912:07 pmRNSHolding(s) in Company
2nd Jul 20195:56 pmRNSHolding(s) in Company
2nd Jul 20195:56 pmRNSHolding(s) in Company
2nd Jul 20195:55 pmRNSHolding(s) in Company
1st Jul 20194:55 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSTotal Voting Rights
25th Jun 20194:57 pmRNSBlock Listing Application
17th Jun 20194:35 pmRNSPrice Monitoring Extension
7th Jun 20196:00 pmRNSHolding(s) in Company
7th Jun 20194:18 pmRNSResult of AGM
6th Jun 20196:23 pmRNSHolding(s) in Company
6th Jun 20194:11 pmRNSHolding(s) in Company
31st May 20197:00 amRNSTotal Voting Rights
28th May 20195:58 pmRNSHolding(s) in Company
28th May 20195:56 pmRNSHolding(s) in Company
21st May 20199:05 amRNSHolding(s) in Company
14th May 20194:24 pmRNSAnnual report and notice of AGM
8th May 20197:00 amRNSPublication of Tudorza Phase IV ASCENT in JAMA
3rd May 20192:18 pmRNSIssue of Equity
1st May 20197:00 amRNSFinal Results
30th Apr 20197:00 amRNSTotal Voting Rights
15th Apr 201911:55 amRNSHolding(s) in Company
1st Apr 20197:00 amRNSFDA approval of Duaklir for treatment of COPD
29th Mar 20194:40 pmRNSSecond Price Monitoring Extn
29th Mar 20194:35 pmRNSPrice Monitoring Extension
29th Mar 20193:58 pmRNSFDA website posts Duaklir NDA approval
29th Mar 20193:34 pmRNSCircassia announces FDA approval of Tudorza sNDA
29th Mar 20197:00 amRNSTotal Voting Rights
5th Mar 20194:53 pmRNSHolding(s) in Company
4th Mar 20194:04 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSTotal Voting Rights
11th Feb 20195:17 pmRNSHolding(s) in Company
8th Feb 20199:00 amRNSNotice of Results
6th Feb 20194:44 pmRNSHolding(s) in Company
6th Feb 20197:00 amRNSHolding(s) in Company
4th Feb 20195:57 pmRNSHolding(s) in Company
4th Feb 20198:06 amRNSSuccessful FDA Presubmission Meeting for AirNOvent
4th Feb 20198:06 amRNSAdmission to AIM
1st Feb 20194:36 pmRNSPrice Monitoring Extension
1st Feb 20194:03 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTotal Voting Rights
30th Jan 20195:30 pmRNSCircassia Pharmaceuticals
30th Jan 20194:41 pmRNSSecond Price Monitoring Extn
30th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20193:30 pmRNSHolding(s) in Company
28th Jan 20193:30 pmRNSHolding(s) in Company
25th Jan 201911:49 amRNSHolding(s) in Company
24th Jan 20197:00 amRNSCommercial rights acquired from AIT Therapeutics
18th Jan 20192:22 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.